technetium-tc-99m-exametazime and Somatoform-Disorders

technetium-tc-99m-exametazime has been researched along with Somatoform-Disorders* in 1 studies

Other Studies

1 other study(ies) available for technetium-tc-99m-exametazime and Somatoform-Disorders

ArticleYear
SPECT imaging of body dysmorphic disorder.
    The Journal of neuropsychiatry and clinical neurosciences, 2004,Summer, Volume: 16, Issue:3

    [99mTc]Hexamethylpropylene amine oxime (HMPAO) single photon emission computed tomography (SPECT) brain scans were undertaken in six subjects with body dysmorphic disorder (BDD). The scans showed a broad range of discrepant findings that do not immediately support a view of BDD as resting on either an obsessive-compulsive or affective disorder spectrum. Nevertheless, involvement of parietal regions is consistent with the characteristic altered body perception of BDD. These preliminary data highlight the need for further systematic functional imaging studies of this condition.

    Topics: Adult; Brain; Female; Humans; Male; Middle Aged; Oximes; Somatoform Disorders; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2004